VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AMRZ
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AMRZAmrize Ltd
$41.87$23.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
AMRZ logo

Amrize Ltd

AMRZ
NYSE · Cement & Aggregates
$41.87
At close - Nov 6, 4:00 PM EST - USD
Market Cap$23.18B
P/E18.7x
52W High$65.94
Volume2.93M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Seasonal Cash Swings Test Amrize's Deleveraging Story

Amrize's revenue re-accelerated 8.5% year-over-year to $3.5B in Q2 2026, and gross margins of roughly 28-30% in non-winter quarters point to real pricing power and operating leverage in its construction materials franchise.

GrowthExpanding
ProfitabilityModerate
ValuationAttractive
TechnicalsWeak
Explore valuation models
MARKET ACTION

AMRZ price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

0/8 Beats

EPS beat 0 of last 8 quarters

02

Valuation risk

-9% Peers

P/E is 9% below peer median

03

Market leadership

RS 35 · Lag

Laggard (Underperforming 65% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Jan 28
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Revenue and gross margins appear to have recovered into the 28-30% range in peak-season quarters, with Q2 2026 operating margin of 20.3% suggesting operating leverage, though Q1 losses (operating margin -3.7%) highlight pronounced seasonality.

Analyst Consensus+11.5% target
Hold(12 analysts)
4 Buy6 Hold2 Sell

The Bull Case

Upside Catalysts

Efficient distribution network

Amrize has over 1,000 sites and a highly efficient distribution network, enabling strong customer delivery capabilities.

Strong Q1 2026 earnings

Amrize's Q1 2026 earnings release indicates solid financial performance, supported by detailed reports and transcripts.

Comprehensive SEC filings

MarketBeat offers access to Amrize's complete SEC filing history, providing transparency and investor confidence.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 11/7/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
AMRZ-23.27%
S&P 500 (^GSPC)+7.63%
1-Year Return
AMRZ-14.46%
S&P 500 (^GSPC)+9.69%
3-Year Return
AMRZ-18.20%
S&P 500 (^GSPC)+66.36%
5-Year Return
AMRZ-18.20%
S&P 500 (^GSPC)+54.31%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y Low
18.7x
Forward P/EExpansion
17.7x
EV/EBITDA0th %ile
9.4x
FCF YieldCash Flow
4.7%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
18.7x
25.3x
0th· Low
EV/EBITDA
9.4x
12.0x
0th· Low
Price/FCF
21.4x
21.1x
100th· High
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$23.56-43.7%
Base (Fair)$40.89-2.3%
Bull$62.21+48.6%
$23.56 Bear$40.89 Base$62.21 Bull
Current Market Price: $41.87
Trades at a 2.4% premium to Base DCF ($40.89)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$11.81B+0.9% YoY
Net income FY25
$1.19B-7.0% YoY
Free cash flow FY25
$1.42B-13.4% YoY
Operating margin FY25
16.1%-2.0 pts YoY
ROIC (FY25)8.3%
Avg ROIC 5Y8.4%
ROE (TTM)9.4%
Piotroski Score4 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate0/8 (0%)
Revenue Beat Rate3/8 (43%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Oct 28, 2026
$1.02-1.0%
vs $1.03
$3.8B-1.5%
vs $3.8B
Q3 2026
Aug 6, 2026
$0.88-7.8%
vs $0.95
$3.5B+3.8%
vs $3.4B
Q2 2026
Apr 29, 2026
-$0.16-18.7%
vs -$0.13
$2.2B+2.4%
vs $2.1B
Q1 2026
Feb 17, 2026
$0.62-4.0%
vs $0.65
$2.8B-2.8%
vs $2.9B
Historical baseline: 8 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Seeking Alpha·1d ago
Stock Picks From Seeking Alpha's October 2026 New Analysts

In October, we welcomed 25 new analysts to Seeking Alpha. This article showcases their stock picks and investment strategies. Analysts provided ratings from Sell to Buy, with detailed justifications based on market trends, company fundamentals, and sector-specific challenges. Key investment theses include bullish views on lululemon athletica, McDonald's, Shoe Station, and the neocloud Nebius.

Business Wire·3d ago
Amrize Expands ‘Made in Canada' Cement Label for Canadian Builders

TORONTO--(BUSINESS WIRE)--Amrize is launching its ‘Made in Canada' label across its domestic cement manufacturing network, offering builders the assurance of Canadian-made manufacturing and quality, supporting local jobs and communities. As Canada's largest cement manufacturer with a highly efficient distribution and logistics network, Amrize is rolling out the ‘Made in Canada' label across its plants from Richmond, British Columbia and Exshaw, Alberta to Bath, Ontario and Brookfield, Nova Scot.

MarketBeat·Oct 30, 2026
What Amrize (AMRZ) Said on Its Q3 Earnings Call

Amrize NYSE: AMRZ reported third-quarter revenue growth of 2.2% as pricing gains and acquisitions offset weather-related volume pressure across construction markets. Net income rose 3.3% to $558 million, while diluted earnings per share increased 4.1% to $1.02, Chairman and Chief Executive Officer Jan Jenisch said on the company's third-quarter earnings call.

The Motley Fool·Oct 29, 2026
Amrize: 3 Key Takeaways for Long-Term Investors

Third-quarter net income increased 3.3% year over year to $558 million. Aggregates pricing increased 6.9% while cement pricing rose 1.8%.

Filtered for Amrize LtdMore Headlines
04

Compare before deciding

Benchmark AMRZ against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Amrize Ltd (AMRZ)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
AMRZ logoAMRZAmrize LtdCurrent
$41.87$23.18B18.740.95%9.93%9.38%—
VMC logoVMCVulcan Materials Company
$282.72$36.68B33.196.94%13.77%13%0.7%
MLM logoMLMMartin Marietta Materials, Inc.
$518.15$31.11B14.640.12%31.95%18.24%0.63%
EXP logoEXPEagle Materials Inc.
$186.04$5.71B15.192.13%16.11%25.16%0.55%
CRH logoCRHCRH plc
$94.81$63.35B18.57-21.11%7.35%13.35%1.23%
BCPC logoBCPCBalchem Corp
$174.43$5.6B32.708.75%15.41%13.21%0.5%

Compare AMRZ vs Peers

Amrize Ltd (AMRZ) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs VMC

Most directly comparable listed peer for AMRZ.

Scale Benchmark

vs CAT

Larger-name benchmark to compare AMRZ against a more recognizable public peer.

Peer Set

Compare Top 5

vs VMC, MLM, EXP, CRH

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

AMRZ SEC Filings & Documents

Amrize Ltd (AMRZ) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Oct 28, 2026·SEC

Material company update

Aug 6, 2026·SEC

Material company update

Apr 29, 2026·SEC

10-K Annual Reports

1
FY 2026

Feb 18, 2026·SEC

10-Q Quarterly Reports

5
FY 2026

Oct 29, 2026·SEC

FY 2026

Aug 10, 2026·SEC

FY 2026

May 7, 2026·SEC

Get notified when AMRZ posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

AMRZ Frequently Asked Questions

Amrize Ltd (AMRZ) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Amrize Ltd's revenue?

Amrize Ltd (AMRZ) reported $12.28B in revenue over the trailing twelve months. Revenue was $11.81B in fiscal year 2025. That is 10% more than the $10.73B of fiscal year 2022.

How fast is Amrize Ltd growing?

Amrize Ltd (AMRZ) grew revenue by 3.9% over the trailing twelve months, compared with the twelve months before.

Is AMRZ profitable?

Yes. Amrize Ltd (AMRZ) earned $1.22B in net income over the trailing twelve months (a 9.9% net margin).

Dividend & Returns
What is AMRZ's return on equity?

Amrize Ltd (AMRZ) had a return on equity (ROE) of 9.4% over the trailing twelve months. That is below the market's typical 10-15%.

What is Amrize Ltd's free cash flow?

Amrize Ltd (AMRZ) generated $1.08B in free cash flow over the trailing twelve months.

What if you invested $1,000 in AMRZ back in 2022?

Total return calculator · dividends reinvested · 4+ years of data

See returns →